2005, NucleaRDB.
This data was extracted from Medline abstracts and full texts (when available) in an automated manner.
The table below describes the selected point mutation and provides links to other documents. The sentence(s) where the point mutation A363Q was found are listed after the table.
The mutated residues are also indicated in the family sequence alignments and hyperlinked to the corresponding mutation pages.
| Point mutation: | A363Q | |
| Cited point mutation: | A330Q | |
| Domain: | LBD HELIX 3 | |
| General numbering (NucleaRDB): | 342 | |
| Protein: | RORA_HUMAN (RORA,NR1F1, RZR) | Swiss-Prot Cross-reference table Family page |
| Protein isoforms | 4 | |
| Other point mutations / same protein / same position | Point mutations at position 363 in RORA_HUMAN | |
| Other point mutations / same protein | List of mutations in RORA_HUMAN | |
| Family alignments |
1F1 ROR alpha 1F RAR-related orphan receptor (ROR,HR3) 1 Thyroid hormone like (TR,RAR,ROR,PPAR,VDR | |
| Other point mutations / same position |
Position 330 in 1F1 ROR alpha family Position 330 in 1F RAR-related orphan receptor (ROR,HR3) family Position 225 in 1 Thyroid hormone like (TR,RAR,ROR,PPAR,VDR family | |
| Reference: | Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A. Kallen J, Schlaeppi JM, Bitsch F, Delhon I, Fournier B J Biol Chem 2004 Apr 2;279(14):14033-8. Epub 2004 Jan 13. | Medline |
| Other point mutations / same article | List | |
| Text source | HTML full text | |
| Validation status | Not yet checked |
Relevant sentences:
A330Q
cmbi.kun.nl), 21-Apr-2005